OOIR: Observatory of International Research

Papers

(The H4-Index of Chest is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
General Information	391
General Information	180
Response	143
General Information	142
A 51-Year-Old Man With Dyspnea and a Pulmonary Nodule	136
The Proton Is Not Enough	136
Attic of Sorrow	130
A 36-Year-Old Patient With Crohn Disease and Bilateral Pleural Effusions	124
“Suction vs Gravity: A Distinction Without a Difference?”	115
Unraveling the Healthy Adherer Effect in the Clinical Management of Sleep Apnea With CPAP	105
WITHDRAWN	95
Rebuttal From Dr Keir and Prof Chalmers	90
WITHDRAWN	87
HEMOTHORAX SECONDARY TO THORACIC ENDOMETRIOSIS	83
KETAMINE TO ASSIST VENTILATOR WEANING AND EXTUBATION IN PATIENTS WHO FAIL SBT FROM SEVERE AGITATION AND ANXIETY	80
DISSEMINATED CRYPTOCOCCAL INFECTION AFTER INITIATION OF BENRALIZUMAB IN A PATIENT WITH ASYMPTOMATIC PULMONARY CRYPTOCOCCUS	78
COVID-ASSOCIATED PULMONARY FIBROSIS: SUBPLEURAL SPARING DISTANCE AS A DISTINGUISHING FEATURE COMPARED TO NON-COVID NONSPECIFIC INTERSTITIAL PNEUMONIA	77
MASSIVE EMPYEMA SECONDARY TO STREPTOCOCCUS CONSTELLATUS INFECTION	76
THE CASCADING EFFECT: A RARE CASE OF EPINEPHRINE-INDUCED CORONARY ARTERY VASOSPASM	75
TURNING OF THE TIDES, WHEN BENIGN BECOMES MALIGNANT: A CASE OF LARGE FIBROUS TUMOR OF THE LUNG	74
AN UNUSUAL PRESENTATION OF A PULSATILE NECK MASS	72
A CHALLENGING DIAGNOSIS OF MULTIPLE PULMONARY NODULES IN AN IMMUNOSUPPRESSED PATIENT WITH APLASTIC ANEMIA WITH CYTOPENIAS: A CASE REPORT	72
Monitoring Biologic Therapy in Asthma Using Functional Imaging	67
PROCEDURAL GUIDANCE FOR EXTRACORPOREAL MEMBRANE OXYGENATION WITH TRANSESOPHAGEAL ULTRASOUND	67
A CASE OF AN ATYPICAL ENDOBROCHIAL LESION	65

WHEN YOU HEAR HOOFBEATS, PREPARE FOR ZEBRAS: A CASE OF SARCOMATOID CARCINOMA	63
WITHDRAWN	63
NONISCHEMIC CARDIOMYOPATHY AND CARDIAC ARREST ATTRIBUTABLE TO ANABOLIC-ANDROGENIC STEROIDS	61
PATHOPHYSIOLOGY OF LACTIC ACIDOSIS IN PATIENTS WITH ASTHMA	61
ISCHEMIC CEREBROVASCULAR SYNDROME, THE DEBUT OF A NEPHROTIC SYNDROME	61
STREPTOCOCCUS AGALACTIAE ENDOCARDITIS OF THE NATIVE VALVE IN THE PATIENT WITH END-STAGE RENAL DISEASE	59
OBSTRUCTIVE LUNG DISEASE CONCORDANCE/DISCORDANCE WHEN COMPARING TWO PREDICTIVE EQUATIONS (GLI VS CRAPO/MORRIS)	59
CHRONIC MYELOID LEUKEMIA COMPLICATED WITH BILATERAL PLEURAL EFFUSIONS SECONDARY TO BOSUTINIB	58
IBRUTINIB-INDUCED SINUS NODE DYSFUNCTION: A RARE CLINICAL ENTITY	56
AMINOPHYLLINE: A FORGOTTEN RESCUE AGENT FOR PATIENTS WITH SEVERE COPD EXACERBATION AND RIGHT HEART FAILURE? A CASE REPORT AND REVIEW OF THE LITERATURE	56
A UNIQUE CASE OF GRANULOMATOSIS WITH POLYANGIITIS COMPLICATED BY THROMBOTIC THROMBOCYTOPENIA PURPURA	56
WITHDRAWN	55
INCIDENCE, CLINICAL CHARACTERISTICS, AND OUTCOMES OF PATIENTS WITH COVID-19 AND FUNGAL COINFECTION	55
DIFFUSE ALVEOLAR HEMORRHAGE SECONDARY TO FENTANYL INHALATION	55
NONCONVULSIVE STATUS EPILEPTICUS: AN IMPORTANT PRESENTATION OF CEFEPIME-INDUCED NEUROTOXICITY	54
ACUTE PULMONARY EMBOLISM IN PATIENTS WITH UNDERLYING PULMONARY HYPERTENSION	54
A QUALITY IMPROVEMENT INITIATIVE TO INCREASE APPROPRIATENESS OF REFERRALS FOR PULMONARY FUNCTION TESTING	53
COMMONLY USED MAGNESIUM SULFATE UNCOMMONLY CAUSING PULMONARY EDEMA	53
POSTSURGICAL VASCULAR OUTCOMES AND THEIR ASSOCIATION WITH OBSTRUCTIVE SLEEP APNEA: RESULTS FROM A NATIONAL COHORT	52
FACTORS INFLUENCING TIME TO DIAGNOSIS AND THE IMPACT OF DIAGNOSTIC DELAYS AND TREATMENT ON SURVIVAL IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION	51
A RARE CASE OF PRIMARY MALIGNANT MELANOMA OF THE LUNG	51
TOXIC TO THE LUNGS: A CASE OF DAPTOMYCIN-INDUCED ACUTE EOSINOPHILIC PNEUMONIA	51
A SEVERE CASE OF MURINE TYPHUS RESULTING IN PROLONGED HOSPITAL STAY AND SURGICAL INTERVENTION: A CASE REPORT	51
SUB-MASSIVE PULMONARY EMBOLISM IN PROFOUND THROMBOCYTOPENIA IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH EXTENSIVE RECURRENT THROMBOSIS: A THERAPEUTIC CHALLENGE AND DILEMMA	51
DRIVER MUTATIONS IN PATIENTS WITH NON-MALIGNANT LUNG DISORDERS	50
PLEOMORPHIC CARCINOMA IN THE MIDST OF COVID	50